Laleman Pharma

Active

Private limited companyfounded 2024active for 2 yearsEsenweg 232, 8600 Diksmuide, BelgiumKBO/BCE: BE 1010.156.713

Summary

Laleman Pharma has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €212,168 and a net result of -€37,832. Its solvency ranks better than 25% of 12,650 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Risk analysisFollow Report Compare

Laleman PharmaActiveChecked score 66/100

Risk analysis Report Compare

Directors

1 director, no change since 2024

Laleman Merel

Director · since 11-06-2024

Current

Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2024, 1 in office

All 1 In office 1

Board

Mandates per person, with start and end dates
Name	Functions and periods
Laleman Merel	Director, from 11-06-2024 to date

See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds

At incorporation act of 11-06-2024 ↗

Laleman Merel 100 shares (100%) · in cash

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years

11-06-2024 Incorporation · €250,000 · 100 shares